Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1α and regulates interferon-γ gene transcription in Th1 cells

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 164-175

  Maruyama, T ^a   Nara, K ^a   Yoshikawa, H ^a   Suzuki, N ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; T cells; Th1 Th2 cells; Transcription factors

Indexed keywords

ADENOSINE TRIPHOSPHATE; ELONGATION FACTOR 1ALPHA; GAMMA INTERFERON; INTERLEUKIN 4; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN TXK; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DNA PROBE; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TH1 CELL;

CELL NUCLEUS; CYTOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; PEPTIDE ELONGATION FACTOR 1; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN-TYROSINE KINASES; TH1 CELLS; TRANSCRIPTION, GENETIC;

EID: 33845476111     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03249.x     Document Type: Article

References (52)

1. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100:655-69.
2. Mullen AC, Hutchins AS, High FA et al. Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol 2002; 3:652-8.
3. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96.
4. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 2003; 4:78-86.
5. Komine O, Hayashi K, Natsume W et al. The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression. J Exp Med 2003; 198:51-61.
6. Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 2005; 308:114-8.
7. Wang D, Matsumoto R, You Y et al. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol 2004; 24:164-71.
8. Gaide O, Favier B, Legler DF et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 2002; 3:836-43.
9. Wang D, You Y, Case SM et al. A requirement for Carma1 TCR-induced NF-kappa B activation. Nat Immunol 2002; 3:830-5.
10. Pomerantz JL, Denny EM, Baltimore D. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J 2002; 21:5184-94.
11. June JE, Wilson LE, Vinuesa CG et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 2003; 18:751-62.
12. Hara H, Wada T, Bakal C et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 2003; 18:763-75.
13. Ryeom S, Greenwald RJ, Sharpe AH, McKeon F. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat Immunol 2003; 4:874-81.
14. Schwartzberg PL, Finkelstein LD, Readinger JA. TEC-family kinases. regulators of T-helper-cell differentiation. Nat Rev Immunol 2005; 5:284-95.
15. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol 2005; 23:549-600.
16. Finkelstein LD, Schwartzberg PL. Tec kinases: shaping T-cell activation through actin. Trends Cell Biol 2004; 14:443-51.
17. Wilcox HM, Berg LJ. Itk phosphorylation sites are required for functional activity in primary T cells. J Biol Chem 2003; 278:37112-21.
18. Miller AT, Wilcox HM, Lai Z, Berg LJ. Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity 2004; 21:67-80.
19. Tomlinson MG, Kane LP, Su J, Kadlecek TA, Mollenauer MN, Weiss A. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Mol Cell Biol 2004; 24:2455-66.
20. Chamorro M, Czar MJ, Debnath J et al. Requirements for activation and RAFT localization of the T-lymphocyte kinase Rlk/Txk. BMC Immunol 2001; 2:3.
21. Schaeffer EM, Broussard C, Debnath J, Anderson S, McVicar DW, Schwartzberg PL. Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med 2000; 192:987-1000.
22. Schneider H, Guerette B, Guntermann C, Rudd CE. Resting lymphocyte kinase (Rlk/Txk) targets lymphoid adaptor SLP-76 in the cooperative activation of interleukin-2 transcription in T-cells. J Biol Chem 2000; 275:3835-40.
23. Rajagopal K, Sommers CL, Decker DC et al. RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation. J Exp Med 1999; 190:1657-68.
24. Kashiwakura J, Suzuki N, Nagafuchi H et al. Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytes. J Exp Med 1999; 190:1147-54.
25. Takeba Y, Nagafuchi H, Takeno M, Kashiwakura J, Suzuki N. Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J Immunol 2002; 168:2365-70.
26. Kashiwakura J, Suzuki N, Takeno M et al. Evidence of autophosphorylation in Txk:Y91 is an autophosphorylation site. Biol Pharm Bull 2002; 25:718-21.
27. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54:375-429.
28. Oliver FJ, Menissier-deMurcia J, Nacci C et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly(ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18:4446-54.
29. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 2001; 276:45588-97.
30. Cervellera MN, Sala A. Poly(ADP-ribose) polymerase is a B-MYB coactivator. J Biol Chem 2000; 275:10692-6.
31. Li M, Naidu P, Yu Y, Berger NA, Kannan P. Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1. Biochem J 2004; 382:323-9.
32. Nie J, Sakamoto S, Song D, Qu Z, Ota K, Taniguchi T. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett 1998; 424:27-32.
33. Miyamoto T, Kakizawa T, Hashizume K. Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase. Mol Cell Biol 1999; 19:2644-9.
34. Peukert S, Schwahn U. New inhibitors of poly(ADP-ribose) polymerase (PARP). Expert Opin Ther Patents 2004; 14:1531-51.
35. Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 2002; 137:761-70.
36. Chiarugi A, Moskowitz MA. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 2003; 85:306-17.
37. Chang WJ, Alvarez-Gonzalez R. The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodifi-cation reaction of poly(ADP-ribose) polymerase 1. J Biol Chem 2001; 276:47664-70.
38. Kameoka M, Ota K, Tetsuka T et al. Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochem J 2000; 346:641-9.
39. Ruscetti T, Lehnert BE, Halbrook J et al. Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase. J Biol Chem 1998; 273:14461-7.
40. Ha HC. Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc Natl Acad Sci USA 2004; 101:5087-92.
41. Griesenbeck J, Ziegler M, Tomilin N, Schweiger M, Oei SL. Stimulation of the catalytic activity of poly(ADP-ribosyl) transferase by transcription factor Yin Yang 1. FEBS Lett 1999; 443:20-4.
42. Scott GS, Kean RB, Mikheeva T et al. The therapeutic effects of PJ34[N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide. HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther 2004; 310:1053-61.
43. Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem 2002; 66:1-21.
44. Edmonds BT, Wyckoff J, Yeung YG et al. Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci 1996; 109:2705-14.
45. Barbarese E, Koppel DE, Deutscher MP et al. Protein translation components are colocalized in granules in oligodendrocytes. J Cell Sci 1995; 108:2781-90.
46. Kim MJ, Si F, Kim SJ et al. The SH2-SH2-SH3 domain of phospholipase C-gamma1 directly binds to translational elongation factor-1alpha. Mol Cells 1999; 9:631-7.
47. Gangwani L, Mikrut M, Galcheva-Gargova Z, Davis RJ. Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells. J Cell Biol 1998; 143:1471-84.
48. Shultz LD, Sweet HO, Davisson MT, Coman DR. 'Wasted', a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature 1982; 297:402-4.
49. Khalyfa A, Bourbeau D, Chen E et al. Characterization of elongation factor-1A (eEF-A-1) and eEF-A-2/S1 protein expression in normal and wasted mice. J Biol Chem 2001; 276:22915-22.
50. Goldowitz D, Shipman PM, Porter JF, Schmidt RR. Longitudinal assessment of immunologic abnormalities of mice with the autosomal recessive mutation, 'wasted'. J Immunol 1985; 135:1806-12.
51. Potter M, Bernstein A, Lee JM. The wst gene regulates multiple forms of thymocyte apoptosis. Cell Immunol 1998; 188:111-7.
52. Sommers CL, Rabin RL, Grinberg A, Tsay HC, Farber J, Love PE. A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection. J Exp Med 1999; 190:1427-38.